Luis Montaner
 | This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages)
|
Luis J. Montaner is an American researcher and executive vice president at The Wistar Institute in Philadelphia, where he leads the Institute’s HIV Cure and Viral Diseases Center as its founding director.[1] Since 2016, Montaner has also served as the principal investigator of the NIH-funded BEAT-HIV Martin Delaney Research Collaboratory, a research consortium that aims to find a cure for HIV through a combination of strategies targeting the viral reservoir.[2][3]
Originally from Puerto Rico, Montaner attended Kansas State University, where he received a Doctor of Veterinary Medicine in 1989. Montaner was admitted to the 1991 class of Marshall Scholars, and in 1995, he obtained his D.Phil. in Experimental Pathology from The University of Oxford.[4][5] After completing his graduate studies, Montaner joined the faculty of The Wistar Institute as an assistant professor. In 2015, he was named the Herbert Kean, M.D., Family Professor.[6]
Research
Montaner’s research career in infectious disease has primarily focused on the HIV-1 virus and potential cure strategies. A 2002 paper from the Montaner Lab in The Journal of Immunology was the first to identify that people living with HIV had marked decreases in dendritic cells, leading to more investigation in their role in HIV. In 2012, his laboratory reported that the AIDS virus could be suppressed by boosting the immune system, thereby reducing patients' reliance on existing antiviral drugs.[7] The AIDS service organization Philadelphia FIGHT partnered with Montaner’s lab at The Wistar Institute in 2014 on a clinical trial to use interferon to strengthen the immune system in patients infected with HIV-1.[8]
Montaner’s HIV research has emphasized the importance of community input to research projects by working closely with research participants and stakeholders within the community of people living with HIV. The BEAT-HIV Collaboratory has received coverage for its efforts to increase community involvement through its community engagement group model.[9]
References
[edit]- ^ "Luis J. Montaner, D.V.M., D.Phil". The Wistar Institute. Retrieved 17 February 2014.
- ^ "RePORT ⟩ RePORTER". reporter.nih.gov. Retrieved 2024-08-14.
- ^ "Home". BEAT-HIV. Retrieved 2024-08-14.
- ^ "Marshall Scholar Alumni by Year from Association of Marshall Scholars". Association of Marshall Scholars. Retrieved 2024-09-23.
- ^ Institute, The Wistar (2023-09-05). "Luis J. Montaner, D.V.M., D.Phil". The Wistar Institute. Retrieved 2024-09-23.
- ^ Institute, The Wistar (2023-09-05). "Luis J. Montaner, D.V.M., D.Phil". The Wistar Institute. Retrieved 2024-09-23.
- ^ Writer, Marie McCullough, Inquirer Staff (2012-03-08). "Penn, Wistar researchers thwart HIV without antiviral drugs". Inquirier. Retrieved 2024-10-04.
{{cite web}}: CS1 maint: multiple names: authors list (link) - ^ Aversa, Kory (2014-01-22). "Philadelphia FIGHT to Participate in Largest Randomized Clinical Trial Searching for a Cure for HIV". Aversa PR & Events, Philadelphia Public Relations. Retrieved 2024-10-04.
- ^ Zipkin, Michele (2023-08-09). "Local scientists share lessons learned from community engagement model of HIV cure research". Philadelphia Gay News. Retrieved 2024-10-04.
   | This biographical article related to medicine in the United States is a stub. You can help Wikipedia by expanding it. |